ascopubs.org4 天
Characteristics and outcomes of patients with early-onset versus average-onset small bowel ...
Molecular and clinical profiling of gastroenteropancreatic (GEP) neuroendocrine tumors (NETs): An analysis of the Oncology Research Information Exchange Network database. This is an ASCO Meeting ...
ascopubs.org4 天
Survival disparities in small intestine carcinoid tumors: A SEER-based analysis.
A phase III study of combination therapy with everolimus plus lanreotide versus everolimus monotherapy for unresectable or recurrent gastroenteropancreatic neuroendocrine tumor (JCOG1901, STARTER-NET) ...
Nature1 个月
A stepwise approach to the management of metastatic midgut carcinoid tumor
After a review by the neuroendocrine multidisciplinary ... further surgical intervention to remove his primary small-bowel carcinoid tumor. Carcinoid tumors commonly originate in the ...
Business Wire6 天
Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Study ...
Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...
Exelixis reports on subgroup analysis of Phase 3 CABINET study
Exelixis (EXEL) announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic ...